Jim Cramer recommends this dividend stock with a 5% performance for “good protection”

We recently published a list of 10 stocks to watch as the commercial wars begin. In this article, let’s take a look at where Bristol-Myers Squibb Company (NYSE: BMY) is against other stocks to watch as the commercial wars begin.

Bill Strazzullo, a market strategist in Bell Curve Trading, said in a last CNBC program that the market was not over and urged investors not to buy all dives and wait for real opportunities. The analyst made some specific predictions on the market’s background:

“I still think it is not over. I think you probably know throughout the board, it is 15% more to go to the disadvantage. Look, the summit was not so difficult to call. It really wasn’t. And I think the background, usually in these main trends when they rolled up, they do the same. They mean Reverts to the 2020 minimum value.”

Strazzullo believes that the S&P 500 could fall to 4,500 to 4,100 before seeing a background. He repeatedly said during the interview that the earnings of the pandemic days are “used”.

“ The key driver was here the manifestation of the minimum of March 2020 at the height of the pandemic when we knew that we were going to have a historical monetary and fiscal stimulus.If you knew that, this was the appropriate trend, you could have known months in advance when the market was going to leave.I gave the goals months in advance. If you lost this basis or technically.

Also read: 7 best shares to buy long -term and 8 cheap actions by Jim Cramer to invest.

For this article, we have chosen 10 Wall Street stocks is looking closely at the United States-Chinese trade war. With each action, we mentioned the number of coverage fund investors. Why are we interested in the stocks that cover the funds? The reason is simple: our research has shown that we can overcome the market by imitating the best stock options for the best coverage funds. The strategy of our quarterly bulletin selects 14 stocks of small layers and large layers each quarter and has returned 373.4% since May 2014, surpassing its reference point at 218 percentage points (Check out more details here)).

Number of Cover Fund Investors: 70

Jim Cramer in a recent CNBC program the recommended investors to buy Bristol-Myers Squibb Co (NYSE: BMY) for dividends in the middle of a loading macroeconomic environment.

“You need to have at least one stock like Bristol Myers or Abbot Labs. They are silly producers and constant with Aby and Bristol that offer good dividend protection, which is much more valuable now that the rates are going down.”